Blog
Join Us at the 2018 Clinical Laboratory Collaborative
Posted by Brandon Savela on Apr 5th 2018
Join us at the 2018 Clinical Laboratory Collaborative - Information and Online Program
Monday, April 23, 2018 - Wednesday, April 25, 2018
7:00 AM - 5:00 PM
Earle Brown Heri …
New Assay | Anti-Certolizumab pegol (Cimzia®) ELISA
Posted by Brandon Savela on Mar 22nd 2018
The drug Certolizumab pegol (trade name Cimzia®) is a tumor necrosis factor alpha
(TNFα) blocker and binds to human TNFα with a KD of 90pM. Certolizumab pegol
is a recombinant, humanized antibody …
New Assay | Ranibizumab (Lucentis®) (mAb-based) ELISA
Posted by Brandon Savela on Mar 15th 2018
The drug Ranibizumab (trade name Lucentis®) is a recombinant humanized IgG1
kappa isotype monoclonal antibody fragment (Fab) designed for intraocular use. Ranibizumab binds to and inhibits the bio …
Product Spotlight | Prorenin Receptor Protein ELISA
Posted by Brandon Savela on Mar 7th 2018
(Pro)renin receptor/(P)RR is a common receptor protein between renin and prorenin. It has an ability equivalent to renin
to bind angiotensinogen and a catalytic activity for conversion from angiot …
Complement System MBL (Lectin) ELISA | An Overview
Posted by Brandon Savela on Mar 2nd 2018
Background
The complement system plays an essential role in chronic, autoimmune and infectious disease. There are three pathways of complement activation, namely the classical, the alternativ …